This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Theranos, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Xinwei Sam Gong: Revolutionizing Sample Analysis
Introduction
Xinwei Sam Gong is an accomplished inventor based in Palo Alto, California. She holds a patent that represents a significant advancement in the field of sample analysis, particularly in reducing the sample volume required for various scientific analyses. Her innovative approach presents an efficient method for detecting and quantifying target substances in reduced volume samples.
Latest Patents
Xinwei Sam Gong is credited with the patent titled "Devices, methods and systems for reducing sample volume." This patent outlines various devices and methods designed to decrease the sample volume necessary for analysis. It introduces inserts that fit within sample containers, as well as alternative sample containers with smaller volume chambers. The methods described in the patent include a range of strategies such as diluting a small-volume sample and optimizing detection through increased illumination, enzyme substrate amounts, and optical detector sensitivity. This versatile patent provides valuable solutions for enhancing detection and quantification processes in laboratory settings.
Career Highlights
Xinwei Sam Gong is currently employed at Theranos, Inc., where she applies her expertise to further innovations in the medical and analytical fields. Her role involves pushing the boundaries of sample analysis technology, making it more efficient and effective. Gong's unique contributions have positioned her as a notable figure in her field.
Collaborations
Throughout her career, Xinwei has collaborated with esteemed colleagues, including Daniel L Young and William Westrick. These partnerships have allowed her to combine innovative ideas and expertise, fostering advancements in sample analysis and related technologies.
Conclusion
Xinwei Sam Gong exemplifies the spirit of innovation through her groundbreaking patent work. By reducing sample volume requirements, she is not only enhancing analytical methods but also contributing to more efficient research practices in the scientific community. Her work at Theranos, Inc. continues to inspire advancements in the field, ensuring that scientific inquiry remains at the forefront of technological development.